For many women recently diagnosed with breast cancer, the treatment process can be overwhelming and stressful. In certain situations, doctors may offer treatment with chemotherapy, targeted therapy or hormonal therapy before surgery to the breast and lymph nodes (neoadjuvant).
The Neoadjuvant Patient Decision Aid has been created by researchers at Breast Cancer Trials to help these women make an informed decision about their treatment. It is recommended for women who have recently been diagnosed with early-stage breast cancer.
The Neoadjuvant Patient Decision Aid was developed and funded by Breast Cancer Trials (Australia and New Zealand) (BCT) and the Patricia Ritchie Centre for Cancer Care and Research, with funding from the HCF Research Foundation. It has been endorsed by the BCT Consumer Advisory Panel. Breast Cancer Network Australia (BCNA) advised on content.
You can access the Neoadjuvant Patient Decision Aid in two ways: a PDF brochure or through this online platform.
8 March 2025
